Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
anatoxine tétanique |
Is a |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
anatoxine diphtérique |
Is a |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clostridium haemolyticum - novyi - perfringens types C & D bacterin - toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clostridium chauvoei - septicum - novyi - sordellii - perfringens types C & D - moraxella bovis bacterin - toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clostridium perfringens type C antitoxin - escherichia coli antiserum |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clostridium perfringens type D antitoxin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bordetella bronchiseptica - clostridium perfringens type C - erysipelothrix rhusiopathiae - escherichia coli - pasteurella multocida bacterin - toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clostridium perfringens types C & D toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pasteurella haemolytica toxoid (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bordetella bronchiseptica - erysipelothrix rhusiopathiae - pasteurella multocida bacterin - toxoid (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clostridium chauvoei - septicum - novyi - sordellii bacterin - toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Borrelia burgdorferi bacterin (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clostridium perfringens type D bacterin - toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clostridium perfringens type C bacterin - toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Salmonella typhimurium bacterin - toxoid (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Transmissible gastroenteritis immunity inducer |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
C & D bacterin - toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mycobacterium cell wall immunostimulant (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Transmissible gastroenteritis vaccine - clostridium perfringens type C - escherichia coli bacterin - toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clostridium perfringens types C & D tetanus toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clostridium perfringens type C antitoxin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Staphylococcus aureus phage lysate (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Flea antigen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clostridium haemolyticum - novyi bacterin - toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Antitoxin (animal) (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clostridium perfringens types C & D bacterin - toxoid (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clostridium chauvoei - septicum - novyi - sordellii - pasteurella haemolytica - multocida bacterin - toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clostridium chauvoei - septicum - novyi - sordellii - perfringens types C & D bacterin - toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clostridium perfringens type C toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clostridium chauvoei - septicum - sordellii - perfringens types |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Toxoid (animal) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clostridium chauvoei - septicum - novyi - sordellii - perfringens types C & D - haemophilus somnus bacterin - toxoid (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clostridium chauvoei - septicum - novyi - sordellii haemophilus somnus bacterin - toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Toxin (animal) (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bordetella bronchiseptica - escherichia coli - pasteurella multocida bacterin - toxoid (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clostridium chauvoei - septicum - haemolyticum - novyi - sordellii - leptospira pomona bacterin - toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clostridium chauvoei - septicum - haemolyticum - novyi - tetani - perfringens types C & D bacterin - toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mycobacterium cell wall fraction immunostimulant |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clostridium chauvoei - septicum - haemolyticum - novyi - sordellii - perfringens types C & D - leptospira pomona - pasteurella haemolytica - multocida bacterin - toxoid (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clostridium chauvoei - septicum - haemolyticum - novyi - sordellii bacterin - toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Staphylococcus aureus bacterin - toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clostridium botulinum type C bacterin - toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clostridium perfringens types C & D - escherichia coli bacterin - toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pasteurella multocida toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clostridium perfringens type C - erysipelothrix rhusiopathiae - escherichia coli bacterin - toxoid (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clostridium chauvoei - septicum - sordellii bacterin - toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bordetella bronchiseptica - pasteurella multocida bacterin - toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Erysipelothrix rhusiopathiae - pasteurella multocida bacterin - toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clostridium botulinum type B toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Autogenous bacterin - toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aeromonas salmonicida bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clostridium chauvoei - septicum - novyi bacterin - toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bacterin - toxoid (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clostridium chauvoei - septicum - haemolyticum - novyi - sordellii - pasteurella haemolytica - multocida bacterin - toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bordetella bronchiseptica - erysipelothrix rhusiopathiae - haemophilus parasuis - pasteurella multocida bacterin - toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clostridium perfringens types C & D antitoxin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clostridium chauvoei - septicum - sordellii - pasteurella haemolytica - multocida bacterin - toxoid (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bordetella bronchiseptica - clostridium perfringens type C - escherichia coli bacterin - toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Propionibacterium acnes immunostimulant (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clostridium chauvoei - septicum - haemolyticum - novyi - sordellii - perfringens types C & D bacterin - toxoid (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clostridium novyi bacterin - toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clostridium perfringens type C escherichia coli bacterin - toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clostridium perfringens type D toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bordetella bronchiseptica - clostridium perfringens type C - escherichia coli - pasteurella multocida bacterin - toxoid (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Escherichia coli bacterin - toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Botulinum toxoid (substance) |
Is a |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Heptavalent equine antitoxin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Trivalent equine antitoxin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Diphtheria vaccine |
Is a |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Parvovirus - pseudorabies vaccine - erysipelothrix rhusiopathiae - leptospira bratislava - canicola - grippotyphosa - hardjo - icterohemorrhagiae - pomona bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bovine rhinotracheitis - parainfluenza 3 vaccine - haemophilus somnus bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Parvovirus vaccine - erysipelothrix rhusiopathiae - leptospira bratislava canicola - grippotyphosa - hardjo - icterohemorrhagiae - pomona bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Corynebacterium pyogenes - pasteurella haemolytica - multocida antiserum |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bordetella bronchiseptica vaccine - erysipelothrix rhusiopathiae - pasteurella multocida bacterin (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Parvovirus vaccine - erysipelothrix rhusiopathiae - leptospira canicola - grippotyphosa - hardjo - icterohaemorrhagiae - pomona - pasteurella multocida bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Parvovirus - pseudorabies vaccine - leptospira canicola - grippotyphosa - hardjo - icterohaemorrhagiae - pomona bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Parvovirus vaccine - leptospira bacterin (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bovine rhinotracheitis - virus diarrhea - parainfluenza 3 - respiratory syncytial virus vaccine - pasteurella haemolytica bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Parvovirus vaccine - erysipelothrix rhusiopathiae - leptospira canicola - grippotyphosa - hardjo - icterohaemorrhagiae - pomona bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Corynebacterium pyogenes - escherichia coli - pasteurella multocida - salmonella typhimurium antiserum |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Transmissible gastroenteritis vaccine - clostridium perfringens type C bacterin - toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Parvovirus - pseudorabies vaccine - erysipelothrix rhusiopathiae - leptospira canicola - grippotyphosa - hardjo - icterohaemorrhagiae - pomona bacterin (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Corynebacterium pyogenes - pasteurella multocida antiserum |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bovine virus diarrhea vaccine - leptospira canicola - grippotyphosa - hardjo - icterohaemorrhagiae - pomona bacterin (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Pentavalent botulinum toxoid vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anatoxine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |